HealWELL AI Inc. Class A
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- James Samuel Lee
- Full Time Employees
- 570
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- 4881 Yonge Street Toronto ON Canada M6G 1A1
- IPO Date
- Jan 6, 2021
- Website
- healwell.ai
- Similar Companies
- Business
- Healwell AI Inc. (TSX:AIDX) develops and commercializes artificial intelligence-powered clinical decision support systems focused on preventative healthcare, enabling early detection of rare, chronic, and complex diseases such as Gaucher disease, chronic kidney disease, and neovascular age-related macular degeneration; the company operates through three segments including Clinical Research and Patient Services via subsidiaries like MCI Polyclinic Group Inc. and BioPharma Services, AI and Data Sciences through Khure Health Inc., Pentavere, and Mutuo for advanced AI integration and rare disease screening, and Healthcare Software encompassing SaaS offerings from Intrahealth and Versource. Healwell AI provides AI tools and software to healthcare providers, health systems, public sector entities, and life sciences organizations across Canada, New Zealand, Australia, the United Kingdom, and globally, leveraging proprietary technologies in data science, electronic health records, and clinical research to improve diagnostic efficiency and patient outcomes. Founded in 2012 and headquartered at 460 College Street, Unit 301 in Toronto, Ontario, the company maintains strategic partnerships including an exclusive alliance with WELL Health Technologies Corp., its largest investor, granting access to over 30,000 Canadian healthcare providers and more than five million annual patient interactions. In recent developments, Healwell AI entered an agreement in December 2024 to acquire 100% of Auckland-based Orion Health Holdings Limited for approximately $165 million CAD following divestiture of non-strategic divisions, integrating Orion's Amadeus and Virtuoso platforms for data interoperability, population health management, and enhanced AI capabilities to serve global public sector clients; the company completed the acquisition by April 2025, positioning it as a global leader in healthcare AI and reporting record revenue growth of 433% in 2024 alongside strategic divestments in November 2025 to transition to a pure-play SaaS, services, and AI business model.
Company News
HEALWELL AI Named to TIME's World's Top HealthTech Companies of 2026 and Announces 12 Real-World Evidence and Clinical AI Presentations at International Conferences This Fall.
HEALWELL AI Provides Research Update on Peer-Reviewed MyHealthNB Study and Global Recognition of DARWEN(TM)
HEALWELL AI to Present at the Cantech Investment Conference on October 8th in Toronto
HEALWELL Expands SMART Summary AI Deployment Across New Brunswick
HEALWELL's DARWEN(TM) AI Outperforms Published Foundation Model Benchmarks and Demonstrates Real-World Patient Impact in New Peer-Reviewed Research
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
HEALWELL to Deploy AI-Powered SMART Search and SMART Summary Across Statewide U.S. Health Information Exchange
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
HEALWELL Achieves Revenue of $33 Million, Improved Operating Cash Flow and a Strengthened Balance Sheet in Q2-2026
HEALWELL AI Announces Conference Call for Second Quarter 2026 Financial Results on August 7, 2026
HEALWELL AI Announces Voting Results of 2026 AGSM
HEALWELL AI Provides Corporate Update: Multi-Province AI Pilot Results Accepted at AMIA Symposium; Alongside Balance Sheet Strengthening with SpaceX Holdings
Healwell AI Inc. (AIDX:CA) Q1 2026 Earnings Call Transcript
HEALWELL Delivers 316% Revenue Growth and Increasing Customer Traction in Q1-2026
HEALWELL AI Announces Conference Call for First Quarter 2026 Financial Results on May 8, 2026
HEALWELL AI Appoints Brad Porter to Board of Directors
HEALWELL to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
Healwell AI Inc. (AIDX:CA) Q4 2025 Earnings Call Transcript
HEALWELL AI Delivers Record Revenue and First Year of Positive Adjusted EBITDA as Global AI Platform Strategy Takes Hold